The United Kingdom’s National Health Services provides universal health coverage at not cost to patients. On the other hand, in the U.S. not all people have insurance, and further insurance can be provided by public entities (e.g., Medicare, Medicaid), private and employer-provided health insurance, and other sources. Whereas the NHS system is highly centralized, the U.S. system is much more decentralized. Could these two systems have anything in common.
According to an article by Maynard, Altman and Stearns (2017), they say that the two systems may aim to have similar forms of reimbursement moving forward.
Increasingly, U.S. reform in terms of payment mechanisms is being emulated by the English. Both systems seek better measurement and management of “value,” that is, the effects of health care on the length and quality of patients’ lives. The hospital systems of both countries are attempting to integrate care function and move away from “fee for service” to bundled or incentive payments.
It looks like care value is important on both sides of the Atlantic. Measuring value as well as setting up policies to incentivize high-value care is exactly the focus of the Innovation and Value Initiative–where I serve as the Director of Research. Although IVI’s focus is largely on the U.S. market, identifying high value treatments is truly a concern for patients, physicians and payers around the globe.
- Maynard, Alan, Stuart H. Altman, and Sally C. Stearns. “Redistribution and redesign in health care: An ebbing tide in England versus growing concerns in the United States.” Health Economics 26, no. 6 (2017): 687-690.